Prime’s signature report — with its deep insights and forecasting — recognized in health care industry as credible source to inform payer strategies
, /PRNewswire/ — Today, Prime Therapeutics LLC (Prime) introduced its 14th annual Medical Pharmacy Trend Report™ (formerly the Magellan Rx Management Medical Pharmacy Trend Report), featuring a holistic view of provider-administered medical benefit drug trends.
The Medical Pharmacy Trend Report is the industry’s premier comprehensive resource that offers detailed analysis of medical benefit drug claims, data benchmarks and current medical benefit drug management strategies. Its three-year forecast by therapeutic class helps payers anticipate evolving trends to make data-informed decisions related to formulary placement, utilization management and cost mitigation strategies.
“Over half of today’s drug spend occurs on the medical benefit,” said Steve Cutts, senior vice president, specialty and clinical solutions at Prime. “Therefore, it is critical to fully understand trends in medical pharmacy. Prime’s deep expertise and robust analytics in this area …